Jubilant Pharmova Share Price
924.50+16.60 (+1.83%)
-12.14% past 1 Year
Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation
Corporate filings & documents
Announcements
Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST
3 days agoReceipt of Show Cause Notice by Jubilant Pharmova Limited - GST
3 days agoNewspaper Publication - Relodgement and KYC Updation
5 days agoReceipt of Show Cause Notice - Jubilant Generics Limited
1 week agoReceipt of Show Cause Notice - Jubilant Generics Limited
1 week agoScrutinizers Report
1 week agoScrutinizers Report
1 week agoOutcome of AGM
1 week agoOutcome of AGM
1 week agoUSFDA Approval for Line 3 Contract manufacturing facility Spokane USA
1 week agoUSFDA Approval for Line 3 Contract manufacturing facility Spokane USA
1 week agoOutcome of Postal Ballot
2 weeks agoOutcome of Postal Ballot
2 weeks agoScrutinizers Report
2 weeks agoScrutinizers Report
2 weeks agoNewspaper Publications
3 weeks agoNewspaper Publications
3 weeks agoPress Release and presentation
3 weeks agoPress Release and presentation
3 weeks agoUn-audited Financial Results for the Quarter ended June 30 2026
3 weeks agoUn-audited Financial Results for the Quarter ended June 30 2026
3 weeks agooutcome of Board meeting
3 weeks agooutcome of Board meeting
3 weeks agoInvestors/ Analysts Meeting
4 weeks agoInvestors/ Analysts Meeting
4 weeks agoJubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoJubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoNewspaper advertisements titled Notice of 48th Annual General Meeting E-voting Record Date and Final Dividend Information
1 month agoIntimation to shareholders about deduction of tax at source (TDS) on Final Dividend for FY 2026-26 if approved by the members at the ensuing AGM
1 month agoIntimation regarding letter dispatched to the shareholders whose email IDs are not registered for AGM Notice TDS Communication and Annual Report of the Company for FY 2025-26
1 month agoPlease find enclosed herewith the Business Responsibility and Sustainability Report for the financial year 2025-26
1 month agoPlease find enclosed herewith the Business Responsibility and Sustainability Report for the financial year 2025-26
1 month agoPlease find attached herewith the Notice of 48th Annual General Meeting alongwith the Annual Report for the Financial Year 2025-26. The 48th AGM of the Company will be held on Wednesday August 26 2026 through Video Conferencing/Other Audio visual means.
1 month agoPlease find attached herewith the Notice of 48th Annual General Meeting alongwith the Annual Report for the Financial Year 2025-26. The 48th AGM of the Company will be held on Wednesday August 26 2026 through Video Conferencing/Other Audio visual means.
1 month agoPursuant to Regulations 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report along with Notice of AGM for the financial year 2025-26. In compliance with circulars issued by the Securities and Exchange Board of India and the Ministry of Corporate Affairs the Annual Report and the Notice of AGM are being sent to the shareholders through electronic mode and are also available on the website of the Company.
1 month agoPursuant to Regulations 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report along with Notice of AGM for the financial year 2025-26. In compliance with circulars issued by the Securities and Exchange Board of India and the Ministry of Corporate Affairs the Annual Report and the Notice of AGM are being sent to the shareholders through electronic mode and are also available on the website of the Company.
1 month agoPursuant to Regulations 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report along with Notice of AGM for the financial year 2025-26. In compliance with circulars issued by the Securities and Exchange Board of India and the Ministry of Corporate Affairs the Annual Report and the Notice of AGM are being sent to the shareholders through electronic mode and are also available on the website of the Company.
1 month agoPursuant to Regulations 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report along with Notice of AGM for the financial year 2025-26. In compliance with circulars issued by the Securities and Exchange Board of India and the Ministry of Corporate Affairs the Annual Report and the Notice of AGM are being sent to the shareholders through electronic mode and are also available on the website of the Company.
1 month agoSubmission of Copies of Newspaper Advertisement relating to Notice to Shareholders - Transfer of equity shares/dividend to IEPF
1 month agoSubmission of Copies of Newspaper Advertisement relating to Notice to Shareholders - Transfer of equity shares/dividend to IEPF
1 month agoJubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Intimation of Board Meeting scheduled for August 07 2026
1 month agoJubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Intimation of Board Meeting scheduled for August 07 2026
1 month agoAnnouncement under Regulation 30 (LODR) - Communication sent to shareholders relating to notice of transfer to IEPF
1 month agoAnnouncement under Regulation 30 (LODR) - Communication sent to shareholders relating to notice of transfer to IEPF
1 month agoSubmission of copies of Newspaper Publications - Annual General Meeting of Jubilant Pharmova Limited scheduled to be held on Wednesday August 26 2026 through Video Conferencing/Other Audio Visual Means.
1 month agoSubmission of copies of Newspaper Publications - Annual General Meeting of Jubilant Pharmova Limited scheduled to be held on Wednesday August 26 2026 through Video Conferencing/Other Audio Visual Means.
1 month agoNewspaper publication - Dispatch of Postal Ballot
1 month agoNewspaper publication - Dispatch of Postal Ballot
1 month agoNotice of Postal Ballot dated July 18 2026
1 month agoNotice of Postal Ballot dated July 18 2026
1 month agoConcalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
Feb 2023
ConcallPresentation
Oct 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
Feb 2022
Oct 2021
Jul 2021
Jun 2021
Feb 2021
ConcallPresentation
Nov 2020
Sept 2020
Corporate Actions
Date
Type
Details
2026-07-24
Dividend
5.0
2025-07-25
Dividend
5.0
2024-08-02
Dividend
5.0
2023-08-10
Dividend
5.0
2022-08-11
Dividend
5.0
2021-08-05
Dividend
5.0
Company details
Registered office
Bhartiagram Gajraula Amroha District Uttar Pradesh PIN: 244223 Tel No: 05924-267437 Fax No: 05924-252352 Email: [email protected] Internet: www.jubilantpharmova.com
Registrars
205-208 , Anarkali Complex,Jhandewala Extension,New Delhi 205-208 , Anarkali Complex Jhandewala Extension NULL PIN: Tel No: 011-23610220-24 Fax No: 011-23552001 Email: NULL
Management
Naresh Kapoor, Company Secretary & Compliance Officer
Shyam S Bhartia, Chairman
Hari S Bhartia, Co-Chairman
Priyavrat Bhartia, Managing Director
Arjun Shanker Bhartia, Joint Managing Director
Sushil Kumar Roongta, Non Executive Independent Director
Vivek Mehra, Non Executive Independent Director
Arun Seth, Non Executive Independent Director
Shirish G Belapure, Non Executive Independent Director
Harsh Mahajan, Non Executive Independent Director
Shivpriya Nanda, Non Executive Independent Director
Details
BSE 530019
NSE JUBLPHARMA
ISIN INE700A01033